Kelly Narine
Technik-/Wissenschafts-/F&E-Leiter bei CARDIOL THERAPEUTICS INC.
Aktive Positionen von Kelly Narine
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CARDIOL THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2020 | - |
Karriereverlauf von Kelly Narine
Ehemalige bekannte Positionen von Kelly Narine
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Neural Therapeutics, Inc.
 Neural Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Neural Therapeutics, Inc. is an ethnobotanical drug-discovery company, which engages in the research and development of dietary supplements and psychedelic-based therapeutic medicines to treat mental ailments. It has established a supply chain in Peru to source certain specimen of mescaline-containing cacti, such as the San Pedro cactus. The company is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | - | 27.06.2024 |
| Independent Dir/Board Member | - | 27.06.2024 | |
Afexa Life Sciences, Inc.
 Afexa Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Afexa Life Sciences, Inc. engages in the development and commercialization of natural-based health products for disease prevention and health maintenance. Its product known as ChemBioPrint is used in the discovery and biological standardization of natural products that deliver consistent, verifiable and provable health benefits. The company was founded by Jacqueline Jie Shan on June 30, 1998 and is headquartered in Edmonton, Canada. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
| AURORA CANNABIS INC. | Corporate Officer/Principal | 01.03.2018 | - |
Ausbildung von Kelly Narine
| University of Alberta | Doctorate Degree |
Statistik
International
| Kanada | 6 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Process Industries | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AURORA CANNABIS INC. | Process Industries |
| CARDIOL THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Neural Therapeutics, Inc.
Neural Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Neural Therapeutics, Inc. is an ethnobotanical drug-discovery company, which engages in the research and development of dietary supplements and psychedelic-based therapeutic medicines to treat mental ailments. It has established a supply chain in Peru to source certain specimen of mescaline-containing cacti, such as the San Pedro cactus. The company is headquartered in Toronto, Canada. | Health Technology |
Afexa Life Sciences, Inc.
Afexa Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Afexa Life Sciences, Inc. engages in the development and commercialization of natural-based health products for disease prevention and health maintenance. Its product known as ChemBioPrint is used in the discovery and biological standardization of natural products that deliver consistent, verifiable and provable health benefits. The company was founded by Jacqueline Jie Shan on June 30, 1998 and is headquartered in Edmonton, Canada. | Commercial Services |
- Börse
- Insiders
- Kelly Narine
- Erfahrung
